Anticoagulant Therapy for Percutaneous Coronary Intervention

被引：62
|
作者：
Rao, Sunil V.
Ohman, E. Magnus [1 ]
机构：
[1] Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC 27710 USA
来源：
CIRCULATION-CARDIOVASCULAR INTERVENTIONS | 2010年 / 3卷 / 01期
关键词：
ELEVATION MYOCARDIAL-INFARCTION; ACTIVATED CLOTTING TIME; GLYCOPROTEIN IIB/IIIA BLOCKADE; REPLACE-2; RANDOMIZED-TRIAL; MOLECULAR-WEIGHT HEPARIN; FACTOR-IXA ACTIVITY; UNFRACTIONATED HEPARIN; INVASIVE STRATEGY; ARTERY-DISEASE; DOUBLE-BLIND;
D O I：
10.1161/CIRCINTERVENTIONS.109.884478
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：80 / 88
页数：9
相关论文
共 50 条
  • [1] Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
    Ten Berg J.M.
    Thijs Plokker H.W.
    Verheugt F.W.A.
    Trials, 2 (3) : 129 - 140
  • [2] Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
    ten Berg, JM
    Plokker, HWT
    Verheugt, FWA
    CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2001, 2 (03): : 129 - 140
  • [3] Adjunctive pharmacologic therapy in percutaneous coronary intervention: Part II anticoagulant therapy
    Kim, Soo-Joong
    Giugliano, Robert P.
    Jang, Ik-Kyung
    CORONARY ARTERY DISEASE, 2011, 22 (02) : 113 - 121
  • [4] Bivalirudin in Percutaneous Coronary Intervention, is it the Anticoagulant of Choice?
    Mahmoud, Ahmed
    Saad, Marwan
    Elgendy, Akram Y.
    Abuzaid, Ahmed
    Elgendy, Islam Y.
    CARDIOVASCULAR THERAPEUTICS, 2015, 33 (04) : 227 - 235
  • [5] Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Gott, Koji
    Nakai, Kentaro
    Shizuta, Satoshi
    Morimoto, Takeshi
    Shiomi, Hiroki
    Natsuaki, Masahiro
    Yahata, Mitsuhiko
    Ota, Chihiro
    Ono, Koh
    Makiyama, Takeru
    Nakagawa, Yoshihisa
    Furukawa, Yutaka
    Kadota, Kazushige
    Takatsu, Yoshiki
    Tamura, Takashi
    Takizawa, Akinori
    Inada, Tsukasa
    Doi, Osamu
    Nohara, Ryuji
    Matsuda, Mitsuo
    Takeda, Teruki
    Kato, Masayuki
    Shirotani, Manabu
    Eizawa, Hiroshi
    Ishii, Katsuhisa
    Lee, Jong-Dae
    Takahashi, Masaaki
    Horie, Minoru
    Takahashi, Mamoru
    Miki, Shinji
    Aoyama, Takeshi
    Suwa, Satoru
    Hamasaki, Shuichi
    Ogawa, Hisao
    Mitsudo, Kazuaki
    Nobuyoshi, Masakiyo
    Kita, Toru
    Kimura, Takeshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (01): : 70 - 78
  • [6] Uninterrupted oral anticoagulant therapy in patients undergoing unplanned percutaneous coronary intervention
    Venetsanos, D.
    Skibniewski, M.
    Janzon, M.
    Lawesson, S.
    Henareh, L.
    Bohm, F.
    Andell, P.
    Karlson, L.
    Simonsson, M.
    Erlinge, D.
    Omerovic, E.
    Alfredsson, J.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2576 - 2576
  • [7] Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention
    Venetsanos, Dimitrios
    Skibniewski, Mikolaj
    Janzon, Magnus
    Lawesson, Sofia S.
    Charitakis, Emmanouil
    Bohm, Felix
    Henareh, Loghman
    Andell, Pontus
    Karlson, Lars O.
    Simonsson, Moa
    Volz, Sebastian
    Erlinge, David
    Omerovic, Elmir
    Alfredsson, Joakim
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (07) : 754 - 763
  • [8] REPLY: Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention
    Venetsanos, Dimitrios
    Skibniewski, Mikolaj
    Alfredsson, Joakim
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (12) : 1382 - 1382
  • [9] Switching Oral Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Franchi, Francesco
    Rollini, Fabiana
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (23) : 2342 - 2345
  • [10] Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention?
    Wong, CK
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (08): : 384 - 385
12345